| Sublingual buccal effervescent SI Pather, RK Khankari, JD Eichman, JR Robinson, J Hontz US Patent 6,200,604, 2001 | 315* | 2001 |
| Current status and the future of buccal drug delivery systems SI Pather, MJ Rathbone, S Şenel Expert Opinion on Drug Delivery 5 (5), 531-542, 2008 | 178 | 2008 |
| Effervescent drug delivery system for oral administration SI Pather, JR Robinson, JD Eichman, RK Khankari, J Hontz, SV Gupte US Patent 6,350,470, 2002 | 169 | 2002 |
| Orally disintegrable tablet forming a viscous slurry JM Siebert, RK Khankari, U Kositprapa, SI Pather US Patent 6,368,625, 2002 | 156 | 2002 |
| Sustained release theophylline tablets by direct compression: Part 1: formulation and in vitro testing SI Pather, I Russell, JA Syce, SH Neau International Journal of Pharmaceutics 164 (1-2), 1-10, 1998 | 156 | 1998 |
| Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipient in buccal tablets HH Alur, SI Pather, AK Mitra, TP Johnston International journal of pharmaceutics 188 (1), 1-10, 1999 | 111 | 1999 |
| Recent developments in buccal and sublingual delivery systems S Şenel, MJ Rathbone, M Cansız, I Pather Expert opinion on drug delivery 9 (6), 615-628, 2012 | 99 | 2012 |
| Effervescent drug delivery system for oral administration SI Pather, JR Robinson, JD Eichman, RK Khankari, J Hontz, SV Gupte US Patent 6,391,335, 2002 | 99 | 2002 |
| Microemulsions as solid dosage forms for oral administration SI Pather, SV Gupte, RK Khankari, J Hontz, JR Robinson, JD Eichman, ... US Patent 6,280,770, 2001 | 99 | 2001 |
| Effervescent drug delivery system for oral administration SI Pather, JR Robinson, JD Eichman, RK Khankari, J Hontz, SV Gupte US Patent 6,641,838, 2003 | 96 | 2003 |
| Porcine buccal mucosa as in vitro model: effect of biological and experimental variables U Kulkarni, R Mahalingam, I Pather, X Li, B Jasti Journal of pharmaceutical sciences 99 (3), 1265-1277, 2010 | 90 | 2010 |
| Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers U Kulkarni, R Mahalingam, SI Pather, X Li, B Jasti Journal of pharmaceutical sciences 98 (2), 471-483, 2009 | 90 | 2009 |
| Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets HH Alur, JD Beal, SI Pather, AK Mitra, TP Johnston Journal of pharmaceutical sciences 88 (12), 1313-1319, 1999 | 85 | 1999 |
| Emulsions as solid dosage forms for oral administration SI Pather, SV Gupte, RK Khankari, J Hontz, R Kumbale US Patent 6,692,771, 2004 | 73 | 2004 |
| Evaluation of the gum from Hakea gibbosa as a sustained-release and mucoadhesive component in buccal tablets HH Alur, SI Pather, AK Mitra, TP Johnston Pharmaceutical development and technology 4 (3), 347-358, 1999 | 69 | 1999 |
| Pharmaceutical compositions for rectal and vaginal administration SI Pather, JR Robinson, JD Eichman, RK Khankari, J Hontz US Patent 6,576,250, 2003 | 63 | 2003 |
| Oral mucosal drug delivery and therapy MJ Rathbone, S Senel, I Pather Springer US, 2015 | 57 | 2015 |
| Effect of experimental temperature on the permeation of model diffusants across porcine buccal mucosa UD Kulkarni, R Mahalingam, X Li, I Pather, B Jasti Aaps Pharmscitech 12, 579-586, 2011 | 54 | 2011 |
| Overview of oral mucosal delivery MJ Rathbone, I Pather, S Şenel Oral mucosal drug delivery and therapy, 17-29, 2015 | 53 | 2015 |
| Enhanced buccal delivery of fentanyl using the OraVescent drug delivery system SI Pather, JM Siebert, J Hontz, R Khankari, R Kumbale, S Gupte Drug Deliv Technol 1 (1), 54-57, 2001 | 52 | 2001 |
